Clinical Trials Logo

Fetal Weight clinical trials

View clinical trials related to Fetal Weight.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06456957 Not yet recruiting - Ultrasound Clinical Trials

Fetal Abdominal Subcutaneous Tissue Thickness in Prediction of Fetal Weight in Term Pregnant Women

Start date: September 2024
Phase:
Study type: Observational

Fetal Abdominal subcutaneous tissue thickness (FASTT) can be easily measured during the routine ultrasound examination of pregnant women. Numerous reports have shown FASTT measurement to be a good way of evaluating subcutaneous fat tissue. However, to the best of our knowledge, no studies have investigated the association of FASTT with abnormal fetal growth in nondiabetic. For this reason, in this study we evaluated whether FASTT can predict birth weight or diagnose LGA and/or LBW infants in the third trimester.

NCT ID: NCT05478798 Not yet recruiting - Pregnancy Related Clinical Trials

Comparison of Three Methods for Fetal Weight Estimation

Start date: August 1, 2022
Phase:
Study type: Observational

The aim of this study was to compare maternal, clinical and ultrasound estimations of fetal weight in women with severe (BMI>35) and morbid (BMI>40) obesity and to determine the effect of maternal body mass index (BMI) on these estimations.

NCT ID: NCT05197101 Not yet recruiting - Macrosomia, Fetal Clinical Trials

To Evaluate the Efficacy and Safety of Balloon Catheter Combined With Oxytocin Induction in Nulliparous Women With Estimated Fetal Weight ≥3500g at 39-40 Weeks of Gestation

Start date: January 17, 2022
Phase: N/A
Study type: Interventional

This study is a randomized, controlled, observational study. 150 nulliparous women with estimated fetal weight ≥3500g at 39-40 weeks of gestation will be enrolled as subjects in the two groups is 1:1. In the experimental group, vaginal examination will be performed at 39 to 40 weeks to assess cervical conditions. If the bishop score <6, the balloon catheter combined with oxytocin induction will be planned at 40 weeks ±3 days. In the control group, one week to 41 weeks ±3 days will be expected. Vaginal examination will be performed again to evaluate cervical conditions. If the bishop score <6 points, and balloon catheter combined with oxytocin induction will be performed. After 96h, their final delivery mode will be recorded. In the following 42 days postpartum, their complications and the neonatal outcome will be followed up.

NCT ID: NCT03857204 Not yet recruiting - Fetal Weight Clinical Trials

Fetus Weight Estimation by Ultrasound Data Collection

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

This research aims to allow deployment & optimization of SAMPL plain wave algorithm so as to make required advancement towards a light-weight portable US platform or wireless probe - thus elevating clinician's care level and patient treatment by allowing more scan availability and flexibility.

NCT ID: NCT03206281 Not yet recruiting - Clinical trials for Ultrasonography, Prenatal

Tall Stature Women Fetal Weight Estimation

TSFW
Start date: July 5, 2017
Phase: N/A
Study type: Observational [Patient Registry]

To investigate the difference of clinical VS sonographic fetal weight estimation of tall women stature (above 10t percentile)